Abstract:Objective To explore the effects of over-expression of Lin28A on glycolysis of gastric cancer cells and the underlying mechanism.Methods Human gastric cancer BGC-823 cells in vitro were stably transfected with lentivirus-mediated over-expression of Lin28A.Lactic acid levels of cell culture medium were detected with biochemical method,phosphofructose kinase (PFK) levels in cells with ELISA,the expression levels of Lin28A,hypoxia-inducible factor (HIF)-1α,glucose transporter (GLUT)-1,and pyruvate kinase M2 (PKM2) were detected using Western blotting,and let-7a RNA using reverse transcription-PCR.Annexin Vallophycocyanin (APC) staining method was used to assess cell apoptosis.Results Compared with the normal control (CON) group and the negative control (NC) group,Lin28A protein level in the over-expression (OE) group was significantly higher (both P ＜0.001).RNA expression level of let-7a was significantly lower in the OE group than in the NC group (0.602 ±0.017 vs.1.001 ±0.063,P =0.005 2).The levels of the HIF-1α,GLUT-1,PKM2 proteins were all significantly lower in the OE group than in the CON and the NC groups (all P ＜ 0.001).The lactic acid levels of cell culture medium in the CON,the NC,and the OE groups were (1.71 ± 0.13),(1.53 ±0.11),(1.24 ±0.04) mmol/L,which was significantly lower in the OE group than in the CON group and the NC group (P =0.017 0,0.031 0).Intracellular PFK level in the OE group was also significantly lower than in the CON group and the NC group [(1.79 ± 0.05) mmol/L vs.(3.71 ± 0.13) rmmol/L,P =0.014 0;(1.79 ± 0.05) mmol/L vs.(3.49 ± 0.14) mmol/L,P =0.036 0].Apoptosis rates of the CON,the NC,and the OE groups were 5.02％ ±0.14％,7.16％ ±0.21％,10.39％ ±0.37％,respectively,which was significantly higher in the OE group than in the CON group and the NC group (P =0.000 5,0.000 7).Conclusion Over-expression of Lin28A can inhibit the expression of let-7a,and induce apoptosis of human gastric cancer cells by suppressing glycolysis of the cells.

Lin28 Mediates Chemoresistance Through Inhibition Of Apoptotic Cell Death In Gastric Carcinoma Cells

Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part Via Microrna-107.

The relationship between Lin28 and the chemotherapy response of gastric cancer

Positive Expression of Lin28 is Correlated with Poor Survival in Gastric Carcinoma

Lin28 Mediates Radiation Resistance Of Breast Cancer Cells Via Regulation Of Caspase, H2a.X And Let-7 Signaling

Lin28 Mediates Paclitaxel Resistance By Modulating P21, Rb And Let-7a Mirna In Breast Cancer Cells

Overexpression of Lin28 Inhibits the Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis of Bgc-823 Gastric Cancer Cells

Lin28 Mediates Cancer Chemotherapy Resistance Via Regulation of Mirna Signaling.

Effects of Lncrna ANRIL-knockdown on the Proliferation, Apoptosis and Cell Cycle of Gastric Cancer Cells.

Oncogenic Mechanisms of Lin28 in Breast Cancer: New Functions and Therapeutic Opportunities.

Impact of Lin28 on Lymph Node Metastasis in Papillary Thyroid Carcinoma

Downregulation of Microrna-17-5p Inhibits Drug Resistance of Gastric Cancer Cells Partially Through Targeting P21.

Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer

Lin28B is a Novel Prognostic Marker in Gastric Adenocarcinoma.

Inhibitory Effect of Over-Expression of Lin28A on Glycosis in Human Gastric Cancer Cells and the Underlying Mechanism

LIN28 is Involved in Glioma Carcinogenesis and Predicts Outcomes of Glioblastoma Multiforme Patients.

Lin28: an Emerging Important Oncogene Connecting Several Aspects of Cancer

Clinical significance of LIN28A gene polymorphisms and expression in pan-cancer: a meta-analysis and bioinformatic analysis

Chemotherapy-Induced Mirna-29C/catenin-δ Signaling Suppresses Metastasis in Gastric Cancer.

Lin28A Regulates Stem-like Properties of Ovarian Cancer Cells by Enriching RAN and HSBP1 mRNA and Up-regulating its Protein Expression

CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling